Electrophysiologic manifestations of cardiac sarcoidosis

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 5, 2013, Pages 485-492

  Zipse, Matthew M ^a   Sauer, William H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial arrhythmias; Atrioventricular block; Cardiac sarcoidosis; Sudden cardiac death risk; Ventricular arrhythmias

Indexed keywords

ANTIARRHYTHMIC AGENT; IMMUNOSUPPRESSIVE AGENT;

AMBULATORY MONITORING; ATRIOVENTRICULAR BLOCK; ELECTROCARDIOGRAM; HEART ATRIUM ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; REVIEW; SARCOIDOSIS; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUDDEN CARDIAC DEATH; TELEMETRY;

CARDIOMYOPATHIES; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; RISK ASSESSMENT; SARCOIDOSIS;

EID: 84881670526     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283644c6f     Document Type: Review

References (30)

1. Chapelon-Abric C, de ZD, Duhaut P, et al. Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine (Baltimore) 2004; 83:315-334
2. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976; 278:455-469
3. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63:86-108
4. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-Term survival in japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88:1006-1010
5. Cain M, Metzl M, Patel A, et al. Are atrial arrhythmias under recognized in patients with cardiac sarcoidosis? J Am Coll Cardiol 2012; 59:E727
6. Viles-Gonzalez JF, Pastori L, Fischer A, et al. Supraventricular arrhythmias in patients with cardiac sarcoidosis: Prevalence, predictors and clinical implications. Chest 2013; 143:1085-1090
7. Olson MD, Zipse M, Schuller JL, et al. Symptomatic heart failure is an uncommon presentation of cardiac sarcoidosis and is associated with a higher rate of ventricular arrhythmias. J Card Fail 2010; 16:S61
8. Schuller JL, Olson MD, Zipse MM, et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol 2011; 22:1243-1248
9. Schuller JL, Lowery CM, Zipse M, et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011; 16:70-76
10. Kato Y, Morimoto S, Uemura A, et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:133-137
11. Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011; 16:140-147
12. Zipse MM, Schuller JL, Katz DF, et al. Atrial arrhythmias are common and arise from diverse mechanisms in patients with cardiac sarcoidosis. Heart Rhythm 2013 (in press
13. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991; 18:937-943
14. Koplan BA, Soejima K, Baughman K, et al. Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006; 3:924-929
15. Jefic D, Joel B, Good E, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: Report from a multicenter registry. Heart Rhythm 2009; 6:189-195
16. Banba K, Kusano KF, Nakamura K, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4:1292-1299
17. Stees CS, Khoo MS, Lowery CM, Sauer WH. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2011; 22:210-213
18. Hiramastu S, Tada H, Naito S, et al. Steroid treatment deteriorated ventricular tachycardia in a patient with right ventricle-dominant cardiac sarcoidosis. Int J Cardiol 2009; 132:e85-e87
19. Uusimaa P, Ylitalo K, Anttonen O, et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008; 10:760-766
20. Ratner SJ, Fenoglio JJ Jr, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986; 90:528-533
21. Ishikawa T, Kondoh H, Nakagawa S, et al. Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest 1984; 85; 445-447
22. Vanga SR, Vacek J, Berenbom L, Lakkireddy DR. Ventricular tachycardia storm-an atypical presentation of sarcoidosis exacerbation. Indian Pacing Electrophysiol J 2009; 9:351-354
23. Ohe T. Radiofrequency ablation for ventricular tachycardia in patients with cardiac sarcoidosis: Is it worth trying? Heart Rhythm 2009; 6:196-197
24. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) - Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117:e350-e408
25. Betensky BP, Tschabrunn CM, Zado ES, et al. Long-Term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012; 9:884-891
26. Schuller JL, Zipse M, Crawford T, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2012; 23:925-929
27. Kron J, Sauer W, Schuller J, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 2013; 15:347-354
28. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237
29. Crawford T, Sarsam S, Mueller G, et al. The role of cardiac magnetic resonance imaging in identifying patients with cardiac sarcoidosis and preserved left ventricular function in predicting ventricular arrhythmias [abstract]. J Am Coll Cardiol 2012; 59:A140
30. Mehta D, Mori N, Goldbarg SH, et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: Role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 2011; 4:43-48